FDA staff finds no new safety problems with Glaxo’s asthma drug – Reuters


Reuters

FDA staff finds no new safety problems with Glaxo's asthma drug
Reuters
(Reuters) – GlaxoSmithKline Plc's respiratory treatment for chronic breathing problems did not show any new safety problems while being tested to treat asthma, a preliminary review by U.S. Food and Drug Administration staff found. The review comes two …
Ad Comm meeting approaches for expanded indication for Glaxo's COPD med Seeking Alpha (registration)

all 5 news articles »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.